Jamaica Plain, MA, United States of America

Bijan Etemad-Moghadam

This inventor holds 1 USPTO granted patent. Top assignee: Mgi Pharma Biologics, Inc.. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bijan Etemad-Moghadam. Retrieved from https://idiyas.com/inventor/bijan-etemad-moghadam

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 43(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Bijan Etemad-Moghadam

Introduction

Bijan Etemad-Moghadam is an accomplished inventor based in Jamaica Plain, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of compounds that address inflammation and autoimmunity.

Latest Patents

Etemad-Moghadam holds a patent for α-MSH related compounds and methods of use. This invention provides polypeptides containing α-MSH that can be utilized to treat diseases characterized by inflammation and/or autoimmunity. The patent also includes α-MSH analogs and nucleic acids encoding polypeptides containing α-MSH and α-MSH analogs, which may be linked to heterologous sequences. Additionally, the invention outlines methods for delivering α-MSH containing peptides, α-MSH analogs, and DNA encoding these compounds.

Career Highlights

Etemad-Moghadam is associated with MGI Pharma Biologics, Inc., where he continues to innovate and contribute to the field of biotechnology. His work focuses on developing therapeutic solutions that can improve patient outcomes in various medical conditions.

Collaborations

Some of his notable coworkers include Mary Lynne Hedley and Robert G Urban, who have collaborated with him on various projects within the company.

Conclusion

Bijan Etemad-Moghadam's contributions to biotechnology through his innovative patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for new treatments that address critical health issues.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…